Intra-Cellular Therapies
ITCI
#1339
Rank
S$18.18 B
Marketcap
$171.14
Share price
-0.19%
Change (1 day)
69.83%
Change (1 year)

EPS for Intra-Cellular Therapies (ITCI)

EPS in 2023 (TTM): -$2.17

According to Intra-Cellular Therapies's latest financial reports the company's current EPS (TTM) is -$2.16. In 2022 the company made an earnings per share (EPS) of -$3.64 an increase over its 2021 EPS that were of -$4.69.

EPS history for Intra-Cellular Therapies from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.17-40.53%
2022-$3.64-22.29%
2021-$4.698.02%
2020-$4.3420.9%
2019-$3.59-5.63%
2018-$3.8033.96%
2017-$2.84-21.19%
2016-$3.60-7.56%
2015-$3.90174.53%
2014-$1.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.33-84.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-$13.39 521.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.87 32.92%๐Ÿ‡บ๐Ÿ‡ธ USA